14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
Have you ever thought about what it would be like to work in a compliance program where you are also...
Read More >
On September 27, 2019, the U.S. District Court for the Northern District of Illinois granted a defen...
Read More >
Warburg Pincus and Martis Capital are merging their respective portfolio companies, Qualifacts and C...
Read More >
Contrary to the U.S. Supreme Court’s restriction of class actions in Wal-Mart Stores, Inc. v. Dukes...
Read More >
New York State Governor Andrew Cuomo recently announced phased reopening of businesses, with the con...
Read More >
Assembly Bill 51 (“AB 51”) prohibits employers from requiring employees to execute arbitration agr...
Read More >